Sweden · Delayed Price · Currency is SEK Coegin Pharma AB Statistics
Total Valuation
NGM:COEGIN has a market cap or net worth of SEK 77.37 million. The enterprise value is 61.81 million.
| Market Cap | 77.37M |
| Enterprise Value | 61.81M |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NGM:COEGIN has 24.88 million shares outstanding. The number of shares has increased by 131.32% in one year.
| Current Share Class | 24.88M |
| Shares Outstanding | 24.88M |
| Shares Change (YoY) | +131.32% |
| Shares Change (QoQ) | +10.98% |
| Owned by Insiders (%) | 11.72% |
| Owned by Institutions (%) | 14.44% |
| Float | 17.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.94 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.71 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.26
| Current Ratio | 7.26 |
| Quick Ratio | 7.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,076.00 |
Financial Efficiency
Return on equity (ROE) is -99.26% and return on invested capital (ROIC) is -62.05%.
| Return on Equity (ROE) | -99.26% |
| Return on Assets (ROA) | -53.93% |
| Return on Invested Capital (ROIC) | -62.05% |
| Return on Capital Employed (ROCE) | -116.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -22.83M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.74% in the last 52 weeks. The beta is 0.93, so NGM:COEGIN's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -53.74% |
| 50-Day Moving Average | 3.52 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 39.48 |
| Average Volume (20 Days) | 24,915 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -14,000 |
| Operating Income | -22.84M |
| Pretax Income | -22.83M |
| Net Income | -22.83M |
| EBITDA | -19.82M |
| EBIT | -22.84M |
| Earnings Per Share (EPS) | -1.03 |
Balance Sheet
The company has 15.56 million in cash and n/a in debt, giving a net cash position of 15.56 million or 0.63 per share.
| Cash & Cash Equivalents | 15.56M |
| Total Debt | n/a |
| Net Cash | 15.56M |
| Net Cash Per Share | 0.63 |
| Equity (Book Value) | 19.62M |
| Book Value Per Share | 0.79 |
| Working Capital | 14.18M |
Cash Flow
| Operating Cash Flow | -21.77M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NGM:COEGIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -131.32% |
| Shareholder Yield | n/a |
| Earnings Yield | -29.51% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 15, 2023. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jun 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |